ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VEC Vectura Group Plc

164.80
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Vectura Group Plc LSE:VEC London Ordinary Share GB00BKM2MW97 ORD 0.0271P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 164.80 164.80 165.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Vectura Share Discussion Threads

Showing 5551 to 5572 of 12050 messages
Chat Pages: Latest  230  229  228  227  226  225  224  223  222  221  220  219  Older
DateSubjectAuthorDiscuss
21/3/2017
16:24
Gotta wonder what all that dumping to go sub 130p was all about........
soundbuy
21/3/2017
14:35
Pawdaw-exactly my sentiments. I'm now keeping my fingers crossed for May 10th, probably the most significant day of the year for VEC.
alexchry
21/3/2017
14:11
As a former skp holder I'm happy with today's results and pleased to see the share price return to levels associated with the take-over, sorry merger. Enough to make me breathe easy for now.
pawdaw
21/3/2017
13:57
pooroldboy, we didn't have a single afternoon reversal whilst you were on holiday ;-)
popper joe
21/3/2017
13:49
like SKP hang on in compared to SKP this is fun
pooroldboy55
21/3/2017
13:44
Poorold-yes we can. Tedium-a lot of PIs have no real patience and sell out irrespective of co prospects-same kind as sold at 128 a few weeks back. This is a growth company in a growth area but quick returns no. However medium to long term they are the road to riches. imo
cumnor
21/3/2017
13:12
Must be due one or two broker updates in light of results exceeding Numis' numbers
cap160
21/3/2017
12:43
God we cant go red today can we!!!!!!!!!!!!!!!!!
pooroldboy55
21/3/2017
12:23
good results and moving in the right direction...
I particulary like the fact 80% of revenue is now recurring.. moves away from dependancy on milestone payments...

sikhthetech
21/3/2017
12:09
Also happy, will poss sell some next financial year as used up my cap gains for tax year.
pooroldboy55
21/3/2017
10:52
No soundboy, very pleased with this. Solid company that's actually growing and making money and things. Generic advair will be a nice boost later this year. Not too bothered about GSK litigation as the company has too many other growth prospects, esp from 2020 on.
cumnor
21/3/2017
10:48
Quiet board considering.......punters dumped at lows??

Hmmmm......

soundbuy
21/3/2017
09:07
All reads well...... :)
soundbuy
21/3/2017
08:54
Well the market is liking this!Maybe back to previous highs sooner than we think..
gswredland
21/3/2017
08:25
You know who you are! ?
richtea1701
21/3/2017
08:24
Are the resident pessimists a little happier now?
richtea1701
21/3/2017
08:00
'The COPD study in China did successfully achieve its primary endpoints.'
This is surprising and positive. Flutiform is a success story and with the approval of a new breath triggered inhaler (K-Haler) it will continue. This will be the first breath-triggered inhaler in the Asthma market using a combination product. And because coordination between activation and inhalation with this kind of MDI is a serious problem for many patients the K-Haler will have a very positive impact.
Looking forward to this approval and launch.
Also very positive the first launch of the 'handheld smart nebuliser FOX® technology (branded as BreelibTM) used by the Group's partner, Bayer' !

chop55
21/3/2017
07:15
'Transformational' will be the bit market likes hopefully.
richtea1701
21/3/2017
07:13
Very good results. James W-L says: "With its proven formulation, device and development capabilities Vectura is well-positioned to accelerate shareholder value creation, capitalising on changes in the market dynamics of the inhaled respiratory market.
verger
20/3/2017
22:27
There should be a lot of potential here for those with (still more) patience.
However, given the rise in the weeks before results, profit taking is likely and a corresponding dip unless results and statement of early prospects surprise to the upside. Any unresolved or new negative issues could greatly exaggerate any dip giving a chance to those looking for a good entry point.

boadicea
20/3/2017
11:32
We need a good increase in ebitda day to get the P/E ratio down.
fhmktg
20/3/2017
10:12
Looks like a very positive view of results is in the market, hope we are not disappointed, not expecting anything significant but happy to be surprised...
diesel
Chat Pages: Latest  230  229  228  227  226  225  224  223  222  221  220  219  Older

Your Recent History

Delayed Upgrade Clock